Christina Mayerhofer

Also affiliated with Massachusetts General Hospital, Harvard Stem Cell Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Cell of origin epigenetic priming determines susceptibility to Tet2 mutation”.

Cell of origin epigenetic priming determines susceptibility to Tet2 mutation

Nature Communications(2024)10.1038/s41467-024-48508-6

N/A

0.488DataRank · unranked

13 citations

Vinay K. Kartha, Fabiana M. Duarte, Trine Kristiansen, Christina Mayerhofer, Rojesh Shrestha +7 more

OGFOD1 enables AML chemo- and nutrient stress resistance by regulating protein synthesis

Cell Metabolism(2025)10.1016/j.cmet.2025.08.008

N/A

0.165DataRank · unranked

2 citations

Dan Li, Trine Kristiansen, Ernst Mayerhofer, Azeem Sharda, Giulia Schiroli +5 more

PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy

Blood(2023)10.1182/blood.2023020331

N/A

0DataRank · unranked

46 citations

Adam S. Sperling, Christina Mayerhofer, Marie McConkey, Jana M. Ellegast, Carmen Da Silva +18 more